Skip to main content
NIH funding notice PA-17-281

In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)

Closed on January 7, 2019.

Posted
May 12, 2017
Close date
January 7, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $451,591 in first-year total cost, median $451,591.

Most frequent study sections

  1. HIV Coinfections and HIV Associated Cancers Study Section[HCAC]1

Most frequent institutions

  1. UNIVERSITY OF NEBRASKA MEDICAL CENTER1
Competing awards under PA-17-281 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Development of humanized transgenic mice for HBV/HIV co-infection studies1R21AI143394-01A1GURUMURTHY, CHANNABASAVAIAHPOLUEKTOVA, LARISA YUNIVERSITY OF NEBRASKA MEDICAL CENTER, NE$451,591HCAC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.